Mark J. O’Connor
Impact in
- Oncology top 0.05%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 84
- PARP inhibition in cancer therapy 60
- Cancer-related Molecular Pathways 10
- Metal complexes synthesis and properties 8
-
- DNA Repair Mechanisms 52
- CRISPR and Genetic Engineering 12
- Cancer therapeutics and mechanisms 8
- Co-authors
- Alan Lau (28 shared papers)Johann S. de Bono (2 shared papers)Andrew Tutt (2 shared papers)Alan Ashworth (2 shared papers)Timothy A. Yap (4 shared papers)Graeme C.M. Smith (7 shared papers)Stan B. Kaye (1 shared paper)Peijun Wu (1 shared paper)
- Journals
- Cancer Research (16 papers)Molecular Cancer Therapeutics (12 papers)Journal of Virology (6 papers)Clinical Cancer Research (5 papers)Oncotarget (4 papers)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Mark J. O’Connor
116 papers receiving 14.2k citations
Mark J. O’Connor's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 8.8k
- Cancer Research 1.7k
- Molecular Biology 8.3k
- Reproductive Medicine 795
- Genetics 1.7k
Countries citing papers authored by Mark J. O’Connor
This map shows the geographic impact of Mark J. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. O’Connor more than expected).
Fields of papers citing papers by Mark J. O’Connor
This network shows the impact of papers produced by Mark J. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. O’Connor. The network helps show where Mark J. O’Connor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. O’Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers Hit paper breakdown → | 2009 | 2851 |
| 2 | Targeting the DNA Damage Response in Cancer Hit paper breakdown → | 2015 | 1132 |
| 3 | Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition Hit paper breakdown → | 2006 | 1034 |
| 4 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Hit paper breakdown → | 2008 | 790 |
| 5 | Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action Hit paper breakdown → | 2016 | 558 |
| 6 | 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1 Hit paper breakdown → | 2008 | 501 |
| 7 | 2012 | 398 | |
| 8 | 2009 | 307 | |
| 9 | 2011 | 296 | |
| 10 | 1999 | 282 | |
| 11 | 2008 | 273 | |
| 12 | 2019 | 254 | |
| 13 | 2005 | 220 | |
| 14 | 2018 | 213 | |
| 15 | 2015 | 199 | |
| 16 | 2005 | 175 | |
| 17 | 2018 | 173 | |
| 18 | 2011 | 162 | |
| 19 | 2013 | 162 | |
| 20 | 2010 | 155 |
About Mark J. O’Connor
Mark J. O’Connor is a scholar working on Oncology, Molecular Biology, Genetics, Epidemiology and Pulmonary and Respiratory Medicine, having authored 122 papers that have together received 14.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (60 papers), DNA Repair Mechanisms (52 papers), CRISPR and Genetic Engineering (12 papers), BRCA gene mutations in cancer (10 papers), Cancer-related Molecular Pathways (10 papers), Cervical Cancer and HPV Research (8 papers), Cancer therapeutics and mechanisms (8 papers) and Metal complexes synthesis and properties (8 papers). The work is most often cited by research in Oncology (8.8k citations), Cancer Research (1.7k citations), Molecular Biology (8.3k citations), Reproductive Medicine (795 citations) and Genetics (1.7k citations). Mark J. O’Connor has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Alan Lau, Johann S. de Bono, Andrew Tutt, Alan Ashworth, Timothy A. Yap, Graeme C.M. Smith, Stan B. Kaye, Peijun Wu, Jan H.M. Schellens and Peter G. Mortimer. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Virology, Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.